Medicated Skin Products Market in the US to 2014 (OTC Healthcare)

Introduction

Medicated Skin Products Market in the US to 2014 (OTC Healthcare) is a comprehensive resource for market and segment level data on value from 2004 to 2014 and market/company shares for 2008-09.This report also provides data on key distribution channels and reveals the leading companies in the US medicated skin products market.

Features and Benefits

• Identify key market segments by analyzing market size data on value for categories
• Design business strategies by gaining insight into quantitative market trends over 2004-09 and expectations for 2010-14
• Identify key companies in the medicated skin products market in the US and design M&A strategies by analyzing market share data


Highlights

•The medicated skin products market in the US increased at a compound annual growth rate of 3% between 2004 and 2009.
• The anti-bacterials category led the medicated skin products market in the US in 2009, with a share of 42.8%.
•Leading player in medicated skin products market in the US is Johnson & Johnson.


Key questions answered

• Which will be the fastest growing segment within the medicated skin products market in the US?
• How will the forecast growth differ from the historic growth exhibited by the medicated skin products market in the US?
• Which company accounted for the largest share of the US medicated skin products market in 2009?

[Studien Infos ausblenden]

TABLE OF CONTENTS
Chapter 1 Executive Summary 2
Summary category level: medicated skin products 2
Chapter 2 Definition 3
Chapter 3 Category Analysis: Medicated Skin Products 8
Value analysis (US Dollar), 2004?09 8
Value analysis (US Dollar), 2009?14 9
Company and brand share analysis 11
Distribution analysis 15
Chapter 4 Macroeconomic Profile 17
Macroeconomic Indicators 17
Chapter 5 Research Methodology 22
Methodology overview 22
Secondary research 23
Market modeling 24
Creating an initial data model 24
Revising the initial data model 24
Creating a final estimate 25
Creating demographic value splits 25
Primary research 25
Data finalization 26
Ongoing research 26

LIST OF FIGURES
Figure 1: Medicated skin products, US, value by segment ($m), 2004?14 10
Figure 2: Medicated skin products, US, category growth comparison, by value, 2004?14 10
Figure 3: Medicated skin products, US, company share by value (%), 2008?09 13
Figure 4: Medicated skin products, US, distribution channels by value (%), 2008?09 16
Figure 5: Annual data review process 23

LIST OF TABLES
Table 1: Medicated skin products category definitions 3
Table 2: Medicated skin products distribution channels 4
Table 3: Medicated skin products, US, value by segment ($m), 2004?09 8
Table 4: Medicated skin products, US, value forecast by segment ($m), 2009?14 9
Table 5: Medicated skin products, US, brand share by value (%), 2008?09 11
Table 6: Medicated skin products, US, value by brand ($m), 2008?09 12
Table 7: Medicated skin products, US, company share by value (%), 2008?09 14
Table 8: Medicated skin products, US, value by company ($m), 2008?09 14
Table 9: Medicated skin products, US, distribution channels by value (%), 2008?09 15
Table 10: Medicated skin products, US, value by distribution channel ($m), 2008?09 15
Table 11: US population, by age group, 2004?09 (millions) 17
Table 12: US population forecast, by age group, 2009?14 (millions) 18
Table 13: US population, by gender, 2004?09 (millions) 18
Table 14: US population forecast, by gender, 2009?14 (millions) 19
Table 15: US nominal GDP, 2004?09 ($bn, nominal prices) 19
Table 16: US nominal GDP forecast, 2009?14 ($bn, nominal prices) 19
Table 17: US real GDP, 2004?09 ($bn, 2000 prices) 20
Table 18: US real GDP forecast, 2009?14 ($bn, 2000 prices) 20
Table 19: US consumer price index, 2004?09 (2000=100) 21
Table 20: US consumer price index, 2009?14 (2000=100) 21


[Inhaltsverzeichnis ausblenden]